Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Sequential metabolism of 7-dehydrocholesterol to steroidal 5, 7-dienes in adrenal glands and its biological implication in the skin

Open access

Abstract

Since P450scc transforms 7-dehydrocholesterol (7DHC) to 7-dehydropregnenolone (7DHP) in vitro, we investigated sequential 7DHC metabolism by adrenal glands ex vivo. There was a rapid, time- and dose-dependent metabolism of 7DHC by adrenals from rats, pigs, rabbits and dogs with production of more polar 5,7-dienes as detected by RP-HPLC. Based on retention time (RT), UV spectra and mass spectrometry, we identified the major products common to all tested species as 7DHP, 22-hydroxy-7DHC and 20,22-dihydroxy-7DHC. The involvement of P450scc in adrenal metabolic transformation was confirmed by the inhibition of this process by DL-aminoglutethimide. The metabolism of 7DHC with subsequent production of 7DHP was stimulated by forscolin indicating involvement of cAMP dependent pathways. Additional minor products of 7DHC metabolism that were more polar than 7DHP were identified as 17-hydroxy-7DHP (in pig adrenals but not those of rats) and as pregna-4,7-diene-3,20-dione (7-dehydroprogesterone). Both products represented the major identifiable products of 7DHP metabolism in adrenal glands. Studies with purified enzymes show that StAR protein likely transports 7DHC to the inner mitochondrial membrane, that 7DHC can compete effectively with cholesterol for the substrate binding site on P450scc and that the catalytic efficiency of 3betaHSD for 7DHP (V(m)/K(m)) is 40% of that for pregnenolone. Skin mitochondria are capable of transforming 7DHC to 7DHP and the 7DHP is metabolized further by skin extracts. Finally, 7DHP, its photoderivative 20-oxopregnacalciferol, and pregnenolone exhibited biological activity in skin cells including inhibition of proliferation of epidermal keratinocytes and melanocytes, and melanoma cells. These findings define a novel steroidogenic pathway: 7DHC-->22(OH)7DHC-->20,22(OH)(2)7DHC-->7DHP, with potential further metabolism of 7DHP mediated by 3betaHSD or CYP17, depending on mammalian species. The 5-7 dienal intermediates of the pathway can be a source of biologically active vitamin D3 derivatives after delivery to or production in the skin, an organ intermittently exposed to solar radiation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0004309

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 7DHC metabolism by rat adrenal glands. Finely cut fragments of rat adrenal glands were incubated in the presence (B–D) or absence (A) of 7DHC (0.5 mM). Boiled adrenal fragments (C) served as an additional negative control. Panel B shows results from an incubation which included trilostane, a 3βHSD inhibitor. Steroids were extracted with methylene chloride and subjected to LC/MC and UV spectra analyses. Panels A–D identifies 7 main products. Product 3 had an identical retention time to 7DHP standard. Panel E shows UV spectra, MS and the predicted structures of the 7 metabolites.
Figure 1 7DHC metabolism by rat adrenal glands. Finely cut fragments of rat adrenal glands were incubated in the presence (B–D) or absence (A) of 7DHC (0.5 mM). Boiled adrenal fragments (C) served as an additional negative control. Panel B shows results from an incubation which included trilostane, a 3βHSD inhibitor. Steroids were extracted with methylene chloride and subjected to LC/MC and UV spectra analyses. Panels A–D identifies 7 main products. Product 3 had an identical retention time to 7DHP standard. Panel E shows UV spectra, MS and the predicted structures of the 7 metabolites.CC BY · PubMed Central
Figure 2 Precursor-product relationship between 7DHC, hydroxy-7DHC, dihydroxy-7DHC and 7DHP defined by their sequential metabolism by rat adrenal glands. A. Chromatogram showing metabolism of 7DHC(S) by adrenal glands. The hydroxy-7DHC (1) and dihydroxy-7DHC (2) products were collected from the HPLC and tested as substrates (see B–E). Product 3 was identified as 7-DHP based on RT, mass and UV spectra. B. Incubation of hydroxy-7DHC (1) with adrenal glands generated dihydroxy-7DHC with RT 34.8 min (2) and 7DHP with RT 15.8 min (3). C. Boiled adrenal glands served as a control for B. D. Incubation of dihydroxy-7DHC (2) with adrenal glands produced 7DHP; note the lack of S and product 1. E. Negative control for D (boiled adrenal glands ). Inserts: UV spectra of compounds 1–3.
Figure 2 Precursor-product relationship between 7DHC, hydroxy-7DHC, dihydroxy-7DHC and 7DHP defined by their sequential metabolism by rat adrenal glands. A. Chromatogram showing metabolism of 7DHC(S) by adrenal glands. The hydroxy-7DHC (1) and dihydroxy-7DHC (2) products were collected from the HPLC and tested as substrates (see B–E). Product 3 was identified as 7-DHP based on RT, mass and UV spectra. B. Incubation of hydroxy-7DHC (1) with adrenal glands generated dihydroxy-7DHC with RT 34.8 min (2) and 7DHP with RT 15.8 min (3). C. Boiled adrenal glands served as a control for B. D. Incubation of dihydroxy-7DHC (2) with adrenal glands produced 7DHP; note the lack of S and product 1. E. Negative control for D (boiled adrenal glands ). Inserts: UV spectra of compounds 1–3.CC BY · PubMed Central
Figure 3 Metabolism of 7-DHC by adrenal glands of different mammalian species. Finely cut fragments of rat (A), rabbit (B), dog (C) and pig (D) adrenals were incubated in the presence (blue) or absence (green) of 7DHC (S). Boiled adrenal fragments served as an additional negative control for the rat (red). The three major products common to all animals studied are numbered 1 to 3 on the chromatograms. Product 3 had an identical retention time, mass, and UV spectra to 7DHP standard.
Figure 3 Metabolism of 7-DHC by adrenal glands of different mammalian species. Finely cut fragments of rat (A), rabbit (B), dog (C) and pig (D) adrenals were incubated in the presence (blue) or absence (green) of 7DHC (S). Boiled adrenal fragments served as an additional negative control for the rat (red). The three major products common to all animals studied are numbered 1 to 3 on the chromatograms. Product 3 had an identical retention time, mass, and UV spectra to 7DHP standard.CC BY · PubMed Central
Figure 4 Metabolism of 7DHC by pig adrenal glands. Fragments of pig adrenal glands were incubated with 0.5 mM 7DHC. Steroids were extracted with methylene chloride and subjected to HPLC and UV spectral analyses. The UV spectrum for all peaks is the same (see arrows). The mass spectra of the collected peaks 1–4 were obtained by direct injection into the MS module of the Bruker Esquire-LC/MS Spectrometer.
Figure 4 Metabolism of 7DHC by pig adrenal glands. Fragments of pig adrenal glands were incubated with 0.5 mM 7DHC. Steroids were extracted with methylene chloride and subjected to HPLC and UV spectral analyses. The UV spectrum for all peaks is the same (see arrows). The mass spectra of the collected peaks 1–4 were obtained by direct injection into the MS module of the Bruker Esquire-LC/MS Spectrometer.CC BY · PubMed Central
Figure 5 Metabolism of 7DHC by adrenal glands in the presence of DL-aminoglutethimide (AGT), trilostane, forscolin and Δ7-reductase inhibitors. A. For rat adrenals transformation of 7DHC (S) to 7DHP (3) was dramatically inhibited by AGT (red) compared to the incubation with 7DHC alone (blue), while accumulation of 22(OH)7DHC (1), 20,22(OH)27DHC (2) and 7DHP (3) was enhanced by trilostane (green). Control incubations performed with boiled adrenal fragments are shown in the inset. Incubations were carried out for 18 h. B. For pig adrenals AGT also inhibited 7DHC metabolism (red) compared to the incubation with 7DHC alone (blue), while trilostane (green) enhanced accumulation of 22(OH)7DHC (1), 20,22(OH)27DHC (2), 7DHP (3) and 17(OH)7DHP (4). Adrenal fragments were incubated for 6 h and controls (inset) were incubated without the substrate. C. For pig adrenals 0.1 mM forscolin (green) stimulated 7DHC metabolism. The labeling and the experimental conditions are the same as in B. D. Fragments of pig adrenal glands were incubated with increasing doses of 7DHC in the presence (T+) or absence (T−) of 0.1 mM trilostane. The chromatograms were processed as described above. Trilostane (T) enhanced accumulation of 22(OH)7DHC (1), 20,22(OH)27DHC (2), 7DHP (3) and 17(OH)7DHP (4) as a function of 7DHC concentration. E. Fragments of rat adrenal glands were incubated with 7DHC (0.5 mM) in presence of AY-9944 or BM15.766 (10 µM or 100 µM) and analyzed by RP-HPLC (see A for peak identification). The chromatograms were processed using ACDLabs software and relative areas for peaks identified above were calculated. Δ7-reductase inhibitors enhanced production of 7DHC metabolites.
Figure 5 Metabolism of 7DHC by adrenal glands in the presence of DL-aminoglutethimide (AGT), trilostane, forscolin and Δ7-reductase inhibitors. A. For rat adrenals transformation of 7DHC (S) to 7DHP (3) was dramatically inhibited by AGT (red) compared to the incubation with 7DHC alone (blue), while accumulation of 22(OH)7DHC (1), 20,22(OH)27DHC (2) and 7DHP (3) was enhanced by trilostane (green). Control incubations performed with boiled adrenal fragments are shown in the inset. Incubations were carried out for 18 h. B. For pig adrenals AGT also inhibited 7DHC metabolism (red) compared to the incubation with 7DHC alone (blue), while trilostane (green) enhanced accumulation of 22(OH)7DHC (1), 20,22(OH)27DHC (2), 7DHP (3) and 17(OH)7DHP (4). Adrenal fragments were incubated for 6 h and controls (inset) were incubated without the substrate. C. For pig adrenals 0.1 mM forscolin (green) stimulated 7DHC metabolism. The labeling and the experimental conditions are the same as in B. D. Fragments of pig adrenal glands were incubated with increasing doses of 7DHC in the presence (T+) or absence (T−) of 0.1 mM trilostane. The chromatograms were processed as described above. Trilostane (T) enhanced accumulation of 22(OH)7DHC (1), 20,22(OH)27DHC (2), 7DHP (3) and 17(OH)7DHP (4) as a function of 7DHC concentration. E. Fragments of rat adrenal glands were incubated with 7DHC (0.5 mM) in presence of AY-9944 or BM15.766 (10 µM or 100 µM) and analyzed by RP-HPLC (see A for peak identification). The chromatograms were processed using ACDLabs software and relative areas for peaks identified above were calculated. Δ7-reductase inhibitors enhanced production of 7DHC metabolites.CC BY · PubMed Central
Figure 6 Time-dependent metabolism of 7DHP is modified by trilostane (T). Fragments of the pig adrenal glands were incubated with 7DHP (S; 0.5 mM) in the absence (A) or presence (B) of trilostane (0.1 mM) and analyzed by RP-HPLC. Boiled adrenal fragments were used as a negative control (blue). The major products of 7DHP metabolism affected by trilostane are marked by numbers. Time-dependent changes in the relative concentration of the identified products in presence (T+) or absence (T-) of trilostane were calculated using ACDLabs software and are presented in C.
Figure 6 Time-dependent metabolism of 7DHP is modified by trilostane (T). Fragments of the pig adrenal glands were incubated with 7DHP (S; 0.5 mM) in the absence (A) or presence (B) of trilostane (0.1 mM) and analyzed by RP-HPLC. Boiled adrenal fragments were used as a negative control (blue). The major products of 7DHP metabolism affected by trilostane are marked by numbers. Time-dependent changes in the relative concentration of the identified products in presence (T+) or absence (T-) of trilostane were calculated using ACDLabs software and are presented in C.CC BY · PubMed Central
Figure 7 Trilostane (T) inhibits and modifies 7DHP (S) metabolism by rat adrenal glands. A. Fragments of rat adrenal glands were incubated with 7DHP (0.5 mM) in the absence (pink) or presence (gray) of trilostane (0.1 mM) and samples analyzed by RP-HPLC. Boiled adrenal fragments (green) or incubations without the substrate (blue) were used as negative controls. B. The relative concentrations of the identified products affected by trilostane (T). The insert shows inhibition of 7DHP consumption by trilostane. Control marked by blue represents or incubations without the substrate.
Figure 7 Trilostane (T) inhibits and modifies 7DHP (S) metabolism by rat adrenal glands. A. Fragments of rat adrenal glands were incubated with 7DHP (0.5 mM) in the absence (pink) or presence (gray) of trilostane (0.1 mM) and samples analyzed by RP-HPLC. Boiled adrenal fragments (green) or incubations without the substrate (blue) were used as negative controls. B. The relative concentrations of the identified products affected by trilostane (T). The insert shows inhibition of 7DHP consumption by trilostane. Control marked by blue represents or incubations without the substrate.CC BY · PubMed Central
Figure 8 LC/MS identification of the products of 7DHP metabolism by pig adrenals. Collected fraction from RT-HPLC experiment were analyzed using the Bruker Esquire-LC/MS Spectrometer as described in Materials and Methods. Numbers correspond to the products identified in Figs 6 and 7.
Figure 8 LC/MS identification of the products of 7DHP metabolism by pig adrenals. Collected fraction from RT-HPLC experiment were analyzed using the Bruker Esquire-LC/MS Spectrometer as described in Materials and Methods. Numbers correspond to the products identified in Figs 6 and 7.CC BY · PubMed Central
Figure 9 Proposed pathways for the in vivo metabolism of 7DHC in the mammalian adrenal gland.
Figure 9 Proposed pathways for the in vivo metabolism of 7DHC in the mammalian adrenal gland.CC BY · PubMed Central
Figure 10 Stimulation of 7DHC transfer between membranes and the inhibition of the side chain cleavage of [cholesterol by 7DHC. A. To study 7DHC transfer between membranes by N-62 StAR protein cholesterol or 7DHC was placed in donor vesicles at a molar ratio to phospholipid of 0.2. The transfer of the sterol to acceptor vesicles at 35°C was measured in the presence or absence of 5 µM N-62 StAR protein. B. Inhibition of the side chain cleavage of [4-14C]cholesterol by 7DHC was determined with substrate and cytochrome P450scc incorporated into phospholipid (PL) vesicles prepared from dioleoyl phosphatidylcholine containing ardiolipin. As indicated in the figure, 7DHC was included in the membrane at a molar ratio to phospholipid of 0.2. The rate of side chain cleavage of [4-14C]cholesterol was determined from the amount of [4-14C]pregnenolone formed.
Figure 10 Stimulation of 7DHC transfer between membranes and the inhibition of the side chain cleavage of [cholesterol by 7DHC. A. To study 7DHC transfer between membranes by N-62 StAR protein cholesterol or 7DHC was placed in donor vesicles at a molar ratio to phospholipid of 0.2. The transfer of the sterol to acceptor vesicles at 35°C was measured in the presence or absence of 5 µM N-62 StAR protein. B. Inhibition of the side chain cleavage of [4-14C]cholesterol by 7DHC was determined with substrate and cytochrome P450scc incorporated into phospholipid (PL) vesicles prepared from dioleoyl phosphatidylcholine containing ardiolipin. As indicated in the figure, 7DHC was included in the membrane at a molar ratio to phospholipid of 0.2. The rate of side chain cleavage of [4-14C]cholesterol was determined from the amount of [4-14C]pregnenolone formed.CC BY · PubMed Central
Figure 11 The effect of 7DHP, pregnacholecalciferol (pD3) and pregnenolone on normal immortalized epidermal HaCaT keratinocytes and PIG1 melanocytes. A and B. Inhibition of HaCaT cell proliferation as measured by [3H]-thymidine incorporation (A) and MTT (B) assays after 48 h and 72 h of treatment, respectively. C. Inhibition of NFκB activity in HaCaT keratinocytes 24 h after transfection with luciferase construct NFκB-Luc. The cells were treated for 24 h with 100 nM vitamin D3 (vD3), 1,25(OH)2D3, 7DHP, pD3, pregnenolone or ethanol vehicle (control) and luciferase activity was measured in cell extracts. D and E. Inhibition of cell growth as measured by sulforhodamine b assay (protein content) after 72 h of treatment of non-pigmented (D) and pigmented (E) PIG1 human melanocytes. Inserts show the color of representative cell pellets. Significant differences versus ethanol-treated control cells were defined as *p<0.05, **p<0.01, ***p<0.001.
Figure 11 The effect of 7DHP, pregnacholecalciferol (pD3) and pregnenolone on normal immortalized epidermal HaCaT keratinocytes and PIG1 melanocytes. A and B. Inhibition of HaCaT cell proliferation as measured by [3H]-thymidine incorporation (A) and MTT (B) assays after 48 h and 72 h of treatment, respectively. C. Inhibition of NFκB activity in HaCaT keratinocytes 24 h after transfection with luciferase construct NFκB-Luc. The cells were treated for 24 h with 100 nM vitamin D3 (vD3), 1,25(OH)2D3, 7DHP, pD3, pregnenolone or ethanol vehicle (control) and luciferase activity was measured in cell extracts. D and E. Inhibition of cell growth as measured by sulforhodamine b assay (protein content) after 72 h of treatment of non-pigmented (D) and pigmented (E) PIG1 human melanocytes. Inserts show the color of representative cell pellets. Significant differences versus ethanol-treated control cells were defined as *p<0.05, **p<0.01, ***p<0.001.CC BY · PubMed Central
Figure 12 7DHP, 20-oxopregnacalciferol (pD3) and pregnenolone inhibit growth of melanoma cells in soft agar. A: hamster AbC1 melanoma; B: human SKMEL-188 melanoma; C: visualization of SKMEL-188 colonies by MTT reagent. Decreased number and size of colonies was observed in both cell lines. Significant differences versus ethanol-treated cells were defined as *p<0.05, **p<0.01, ***p<0.001.
Figure 12 7DHP, 20-oxopregnacalciferol (pD3) and pregnenolone inhibit growth of melanoma cells in soft agar. A: hamster AbC1 melanoma; B: human SKMEL-188 melanoma; C: visualization of SKMEL-188 colonies by MTT reagent. Decreased number and size of colonies was observed in both cell lines. Significant differences versus ethanol-treated cells were defined as *p<0.05, **p<0.01, ***p<0.001.CC BY · PubMed Central
Figure 13 Metabolism of 7DHC and 7DHP by rat skin. A. To study the skin capability to transform 7DHC to 7DHP isolated mitochondria were incubated with 7DHC (0.5 mM) in the presence (experimental) or absence (control) of isocitrate and NADPH. 7DHP: product with the same retention time and UV spectra (inset) as 7DHP standard. B. Incubation of crude skin extract with 7DHP substrate (RT 16.7 min) in the presence of isocitrate and NADPH (experimental) resulted in appearance of a 5,7-diene product (N) with RT 11.9 min, which was absent in control reaction mixture (isocitrate and NADPH were not added) (control).
Figure 13 Metabolism of 7DHC and 7DHP by rat skin. A. To study the skin capability to transform 7DHC to 7DHP isolated mitochondria were incubated with 7DHC (0.5 mM) in the presence (experimental) or absence (control) of isocitrate and NADPH. 7DHP: product with the same retention time and UV spectra (inset) as 7DHP standard. B. Incubation of crude skin extract with 7DHP substrate (RT 16.7 min) in the presence of isocitrate and NADPH (experimental) resulted in appearance of a 5,7-diene product (N) with RT 11.9 min, which was absent in control reaction mixture (isocitrate and NADPH were not added) (control).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 91

Metadata

Authors
Slominski, A. T., Zmijewski, M. A., Semak, I., Sweatman, T., Janjetovic, Z., Li, W., Zjawiony, J. K., & Tuckey, R. C.
Affiliations
  • University of Tennessee Health Science Center (US)
  • Belarusian State University (BY)
  • University of Mississippi (US)
  • The University of Western Australia (AU)
Corresponding author
Slominski, Andrzej T.
Venue
PLoS ONE
Published
2009-02-03
Volume
4
Issue
2
Pages
e4309
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2082168591
Cited by
90
References
61
Citations by year
2025: 4 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 7 · 2013: 8 · 2012: 11
FWCI
3.62
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (University of Western Australia) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Cancer Institute (R15CA125623)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190)
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
7-dehydrocholesterol, steroidogenesis, CYP11A, steroidogenic acute regulatory protein, 3β-hydroxysteroid dehydrogenase, adrenal gland, cAMP signaling, forskolin, epidermal keratinocytes, melanocytes, melanoma
MeSH terms
Adrenal Glands, Alkenes, Animals, Chromatography, Liquid, Dehydrocholesterols, Enzyme Inhibitors, Enzymes, Female, Humans, Male, Melanocytes, Melanoma, Pregnatrienes, Secosteroids, Skin, Mass Spectrometry, Time Factors, Tissue Extracts, Keratinocytes, Cell Proliferation, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sequential metabolism of 7-dehydrocholesterol to steroidal 5, 7-dienes in adrenal glands and its biological implication in the skin. https://app.cochat.ai/papers/10.1371/journal.pone.0004309
The paper
Slominski, A. T., Zmijewski, M. A., Semak, I., Sweatman, T., Janjetovic, Z., Li, W., Zjawiony, J. K., & Tuckey, R. C. (2009). Sequential metabolism of 7-dehydrocholesterol to steroidal 5, 7-dienes in adrenal glands and its biological implication in the skin. PLoS ONE. https://doi.org/10.1371/journal.pone.0004309

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.